Elanco CEO awarded new deferred stock units
Simmons Jeffrey N reported acquisition or exercise transactions in this Form 4 filing.
Rhea-AI Filing Summary
Simmons Jeffrey N reported acquisition or exercise transactions in this Form 4 filing.
Elanco Animal Health Inc reported that President, CEO and Director Jeffrey N. Simmons received a grant of 113.4857 deferred stock units on 2026-07-24 at $24.9100 per unit, increasing his direct deferred stock unit holdings to 24,884.3878 units. Each unit represents the right to receive one share of common stock or the cash equivalent and will settle in cash or shares after termination of employment or in a specified future year under the company’s Executive Deferral and Stock Match Plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Deferred Stock Units F1, F2 | 113.4857 | $24.91 | $3K |
Footnotes (2)
- F1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
- F2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.
Key Figures
Key Terms
Deferred Stock Units financial
cash equivalent financial
Executive Deferral and Stock Match Plan financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Elanco (ELAN) report for Jeffrey N. Simmons?
What are the deferred stock units granted to Elanco (ELAN) CEO Jeffrey N. Simmons?
When will the deferred stock units granted at Elanco (ELAN) to the CEO settle?
How many deferred stock units does Elanco (ELAN) CEO hold after this grant?
Does the Elanco (ELAN) deferred stock unit grant to the CEO involve underlying common stock?
AI-generated analysis. How Rhea-AI works. Not financial advice.